Sertoli Cells Express Accommodation, Survival, and Immunoregulatory Factors When Exposed to Normal Human Serum.

Sertoli cells complement immune regulation xenotransplantation

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
06 Jun 2023
Historique:
received: 12 05 2023
revised: 30 05 2023
accepted: 03 06 2023
medline: 28 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

Transplantation is a clinical procedure that treats a variety of diseases yet is unattainable for many patients due to a nationwide organ shortage and the harsh side effects of chronic immune suppression. Xenografted pig organs are an attractive alternative to traditional allografts and would provide an endless supply of transplantable tissue, but transplants risk rejection by the recipient's immune system. An essential component of the rejection immune response is the complement system. Sertoli cells, an immunoregulatory testicular cell, survive complement as xenografts long term without any immune suppressants. We hypothesized that exposure to the xenogeneic complement influences Sertoli cell gene expression of other accommodation factors that contribute to their survival; thus, the purpose of this study was to describe these potential changes in gene expression. RNA sequencing of baseline neonatal pig Sertoli cells (NPSC) as compared to NPSC after exposure to normal human serum (NHS, containing complement) revealed 62 significantly differentially expressed genes (DEG) that affect over 30 pathways involved in immune regulation, cell survival, and transplant accommodation. Twelve genes of interest were selected for further study, and Sertoli cell protein expression of CCL2 and the accommodation factor A20 were confirmed for the first time. Functional pathway analyses were conducted in NPSC and three biological clusters were revealed as being considerably affected by NHS exposure: innate immune signaling, cytokine signaling, and T cell regulation. Better understanding of the interaction of Sertoli cells with complement in a xenograft environment may reveal the mechanisms behind immune-privileged systems to increase graft viability.

Identifiants

pubmed: 37371745
pii: biomedicines11061650
doi: 10.3390/biomedicines11061650
pmc: PMC10296330
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : CH Foundation
ID : N/A

Références

Genome Res. 2007 Oct;17(10):1537-45
pubmed: 17785539
Front Oncol. 2021 Jul 27;11:722916
pubmed: 34386431
Acta Physiol Hung. 2007 Mar;94(1-2):67-81
pubmed: 17444276
Mol Immunol. 2017 Sep;89:2-9
pubmed: 28601357
Cancer Immunol Res. 2019 Mar;7(3):376-387
pubmed: 30696630
Front Immunol. 2014 Jul 14;5:327
pubmed: 25071785
JCI Insight. 2019 Nov 1;4(21):
pubmed: 31581152
Cancer Cell Int. 2015 Nov 05;15:106
pubmed: 26549987
Bioessays. 2010 Dec;32(12):1067-76
pubmed: 20954179
Cancer Lett. 2019 Jun 28;452:244-253
pubmed: 30928379
Curr Opin Organ Transplant. 2010 Aug;15(4):411-5
pubmed: 20613526
Front Immunol. 2015 Jun 29;6:317
pubmed: 26175731
Vaccines (Basel). 2016 Jun 24;4(3):
pubmed: 27348007
Eur J Immunol. 2011 Feb;41(2):306-12
pubmed: 21268001
Front Immunol. 2019 Oct 01;10:2306
pubmed: 31632397
Nucleic Acids Res. 2013 Jan;41(Database issue):D1228-33
pubmed: 23180781
Curr Opin Organ Transplant. 2019 Feb;24(1):12-19
pubmed: 30507704
Front Immunol. 2015 May 26;6:257
pubmed: 26074922
Cell Transplant. 2008;17(5):525-34
pubmed: 18714671
J Immunol. 2010 Mar 1;184(5):2321-8
pubmed: 20130212
Curr Opin Organ Transplant. 2009 Feb;14(1):16-22
pubmed: 19337141
Genome Res. 2013 Nov;23(11):1885-93
pubmed: 23934932
Reproduction. 2010 Mar;139(3):495-504
pubmed: 19995832
Proc Am Thorac Soc. 2007 Jul;4(3):247-51
pubmed: 17607007
F1000Res. 2019 Jan 28;8:
pubmed: 30755793
Cell Transplant. 2020 Jan-Dec;29:963689720947102
pubmed: 32841048
Front Immunol. 2021 May 07;12:667177
pubmed: 34025668
Xenotransplantation. 2021 Nov;28(6):e12718
pubmed: 34800323
Int J Mol Sci. 2023 Jan 18;24(3):
pubmed: 36768217
Cell. 2010 Mar 19;140(6):805-20
pubmed: 20303872
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Eur J Immunol. 2009 Nov;39(11):3000-9
pubmed: 19658090
J Immunol. 2015 Dec 15;195(12):5525-31
pubmed: 26637661
Immunol Rev. 2003 Oct;195:58-71
pubmed: 12969310
Science. 2002 May 31;296(5573):1634-5
pubmed: 12040173
Front Immunol. 2014 Sep 25;5:461
pubmed: 25309543
Front Cell Dev Biol. 2020 May 21;8:365
pubmed: 32671059
N Engl J Med. 2022 Jul 7;387(1):35-44
pubmed: 35731912
Immunogenetics. 2007 May;59(5):333-48
pubmed: 17294181
Nucleic Acids Res. 2015 Jan;43(Database issue):D36-42
pubmed: 25355515
Cancer Prev Res (Phila). 2009 Sep;2(9):823-9
pubmed: 19737986
Periodontol 2000. 2015 Oct;69(1):142-59
pubmed: 26252407
Eur J Immunol. 1998 Nov;28(11):3886-90
pubmed: 9842932
Immunity. 1997 Nov;7(5):609-18
pubmed: 9390685
Transplantation. 2003 May 15;75(9):1594-6
pubmed: 12792521
Cancer Sci. 2022 Mar;113(3):875-890
pubmed: 34978120
BMC Immunol. 2009 Jan 09;10:3
pubmed: 19134210
Annu Rev Immunol. 2018 Apr 26;36:309-338
pubmed: 29677470
Xenotransplantation. 2003 Nov;10(6):577-86
pubmed: 14708526
Diabetes. 1997 Feb;46(2):317-22
pubmed: 9000711
J Immunol. 1998 Jan 1;160(1):369-75
pubmed: 9551993
Tissue Antigens. 2014 Oct;84(4):370-7
pubmed: 25112903
J Am Soc Nephrol. 2010 Jun;21(6):933-42
pubmed: 20299353
Front Immunol. 2022 Jun 09;13:913502
pubmed: 35757731
Cell Transplant. 2007 Nov;16(10):1029-1038
pubmed: 28866926
Mediators Inflamm. 2015;2015:794143
pubmed: 26576076
Immunol Rev. 2008 Jun;223:87-113
pubmed: 18613831
Biol Reprod. 2005 May;72(5):1224-31
pubmed: 15659703
Curr Opin Organ Transplant. 2010 Aug;15(4):456-61
pubmed: 20616728
Neoplasia. 2017 Mar;19(3):237-249
pubmed: 28254151
Signal Transduct Target Ther. 2017;2:
pubmed: 29158945

Auteurs

Rachel L Washburn (RL)

Department of Cell Biology and Biochemistry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79424, USA.
Department of Immunology and Molecular Microbiology, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79424, USA.

Dalia Martinez-Marin (D)

Department of Cell Biology and Biochemistry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79424, USA.
Department of Immunology and Molecular Microbiology, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79424, USA.

Tyler Sniegowski (T)

Department of Cell Biology and Biochemistry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79424, USA.

Ksenija Korać (K)

Department of Cell Biology and Biochemistry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79424, USA.

Alexis R Rodriguez (AR)

Department of Cell Biology and Biochemistry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79424, USA.

Jonathan M Miranda (JM)

Department of Cell Biology and Biochemistry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79424, USA.

Beverly S Chilton (BS)

Department of Cell Biology and Biochemistry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79424, USA.

Robert K Bright (RK)

Department of Immunology and Molecular Microbiology, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79424, USA.

Kevin Pruitt (K)

Department of Immunology and Molecular Microbiology, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79424, USA.

Yangzom D Bhutia (YD)

Department of Cell Biology and Biochemistry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79424, USA.

Jannette M Dufour (JM)

Department of Cell Biology and Biochemistry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79424, USA.

Classifications MeSH